openEHR Community

See the following -

openEHR Community Rises to the Challenge of Coronavirus

Press Release | OpenEHR | March 11, 2020

The global openEHR community led by the major openEHR vendors DIPS (Norway) and Better (Slovenia) have today released open source components to assist software developers creating applications and services to help those fighting the global Coronavirus (COVID-19) pandemic. When the first case of Coronavirus arrived in Norway, Bjørn Næss from DIPS (Norway's largest supplier of hospital IT systems) recognised the need to rapidly develop software to help monitor the outbreak, and reduce the data collection burden on overstretched health workers.

Read More »

openEHR 2020 - International Community Event

Event Details
Type: 
Seminar/Webinar
Date: 
November 24, 2020 (All day)

Hosted by Digital Health and taking place on 24 November, 9am - 5pm (GMT), join us to discover the latest developments, insights and best practice openEHR case studies from a variety of international digital health leaders, including renowned speakers such as Robert Wachter, MD, University of California, San Francisco Department of Medicine Chair and author of The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine's Computer Age book, Mike Jones, VP, Gartner Group, CIO Advisory Healthcare, Aloha McBride, EY Global Health Leader, and many more. Read More »

openEHR international use-cases: The importance of open data

Event Details
Type: 
Seminar/Webinar
Date: 
May 12, 2022 (All day)

Cattedra: Crossborder collaboration and regional joint registries. An innovative diagnosis of rare immune-mediated inflammatory diseases in children made possible with openEHR. The Cattedra project set up a joint registry and data exchange on rare diseases for children in the area of paediatric rheumatology using open data. The project connects Italian children’s hospital IRCCS Burlo Garofolo in Trieste and Slovenian University Medical Centre Ljubljana (the Division of Paediatrics). With openEHR data models and input forms, the partners aim to share knowledge and work on improving the therapeutic methodologies and diagnostic possibilities of rare immune-mediated inflammatory diseases in children.

Read More »